877773-17-6

Basic information

• Product Name: 6-TRIFLUOROMETHYL-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER
• Synonyms: 6-TRIFLUOROMETHYL-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER;1H-Indazole-3-carboxylic acid, 6-(trifluoroMethyl)-, Methyl ester;Methyl 6-(trifluoromethyl)-1H-indazole-3-carboxylate
• CAS NO: 877773-17-6
• Molecular Formula: C₁₀H₇F₃N₂O₂
• Molecular Weight: 244.17
• Mol File: 877773-17-6.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-TRIFLUOROMETHYL-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 6-TRIFLUOROMETHYL-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER(877773-17-6)
• EPA Substance Registry System: 6-TRIFLUOROMETHYL-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER(877773-17-6)

Safety Data

• Hazardous Substances Data: 877773-17-6(Hazardous Substances Data)

Usage

General Description

6-Trifluoromethyl-1H-indazole-3-carboxylic acid methyl ester is a chemical compound with the molecular formula C10H17F3N2O2. It is a methyl ester derivative of 6-Trifluoromethyl-1H-indazole-3-carboxylic acid, which is a potential intermediate in the synthesis of pharmaceutical compounds. This chemical is often used in medicinal and pharmaceutical research for the development of new drugs. Its unique properties make it suitable for various applications in drug discovery and development, especially in the field of medicinal chemistry.

InChI:InChI=1S/C10H7F3N2O2/c1-17-9(16)8-6-3-2-5(10(11,12)13)4-7(6)14-15-8/h2-4H,1H3,(H,14,15)

Upstream product

• 13544-07-5 methyl 2-(2-nitro-4-(trifluoromethyl)phenyl)acetate 
• 290825-52-4 dimethyl 2-(2-nitro-4-trifluoromethylphenyl)malonate 
• 121-17-5 2-chloro-3-nitro-5-trifluoromethylbenzene 

Downstream Products

• 877766-69-3 3-[1-(2,4-dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-propionic acid ethyl ester 
• 877768-45-1 trans-2-[1-(2,4-dichloro-benzyl)-6-trifluoromethyl-1H-indazol-3-yl]-cyclopropanecarboxylic acid 
• 877773-21-2 1-(2,4-dichlorobenzyl)-6-(trifluoromethyl)-1H-indazole-3-carbaldehyde 
• 877768-41-7 3-[1-(2,4-dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-oxirane-2-carboxylic acid 
• 877772-09-3 (1-(2,4-dichlorobenzyl)-6-(trifluoromethyl)-1H-indazol-3-yl)methanol 
• 877766-45-5 (E)-3-(1-(2,4-dichlorobenzyl)-6-(trifluoromethyl)-1H-indazol-3-yl)acrylic acid 
• 877768-84-8 H₂-gamendazole 
• 877766-73-9 3-[1-(2,4-dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-acrylic acid ethyl ester 
• 877773-31-4 3-[1-(2,4-Dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-acrylic acid ethyl ester 
• 877768-95-1 3-[1-(2,4-dichlorobenzyl)-5-trifluoromethyl-1H-indazol-3-yl]-propionic acid 
• 877766-37-5 methyl 1-(2,4-dichlorobenzyl)-6-(trifluoromethyl)-1H-indazole-3-carboxylate 
• 877773-19-8 2-(2,4-dichlorobenzyl)-6-trifluoromethyl-2H-indazole-3-carboxylic acid methyl ester 

Relevant articles and documents

LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT

Fertility management can include: administering to the subject one or more doses of a compound according to Formula I so as to reduce fertility in the subject. Fertility management can also include administering an effective amount of the compound to: impair Sertoli cell function in a male subject; inhibit spermatogenesis in the subject; reduce testis weight in the subject; reduce ovary weight in a female subject; reduce serum progesterone in the female subject; impair ovarian follicle function in the female subject; causing reversible fertility in the subject. In order to return fertility, the method can include ceasing administration of the compound to the subject so as to return fertility in the subject. The compound can be administered for irreversibly sterilizing the subject.